EFFICACY OF MEDICAL TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION BY MEANS OFAMLODIPIN
Abstract
About the Authors
N. A. VelichkoRussian Federation
L. N. Yarshova
Russian Federation
L. M. Boldyreva
Russian Federation
T. V. Kachanova
Russian Federation
References
1. Арабидзе Г.Г., Белоусов Ю.Б., Карпов Ю. А. Артериальная гипертония: справочное руководство для врачей. — М.: Ремедиум, 1999.
2. Белоусов Ю.Б., Грацианский Н.А. Клиническая фармакология амлодипина (новарска). — М.: Univers Publ, 1998.
3. Оганов Р.Г. //Кардиология. - 1999. - № 39. - С. 4-9.
4. Prevention of coronary heart disease in clinical practice : Recommendations of Second ГоШ Task Force of European and other Societies on cirinary prevention // Eur. Heart J. - 1998. - Vol. 19. - P. 1434-1503.
5. The MRFITReserch Group. Risk factor changes and mortality results. - JAMA. - 1982. - Vol. 248. - P. 1465-1477.
Review
For citations:
Velichko N.A., Yarshova L.N., Boldyreva L.M., Kachanova T.V. EFFICACY OF MEDICAL TREATMENT OF PATIENTS WITH ESSENTIAL HYPERTENSION BY MEANS OFAMLODIPIN. Pacific Medical Journal. 2005;(1):66-67. (In Russ.)